Showing results (1421-1430 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|September 12, 2012
Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotypeYuji Piao, Ji Liang, Lindsay Holmes, et al.
Neuro-Oncology|August 8, 2012
A population-based study on the effect of temozolomide in the treatment of glioblastoma multiformePål A Rønning, Eirik Helseth, Torstein R Meling, et al.
Neuro-Oncology|September 29, 2012
Lack of efficacy of bevacizumab + irinotecan in cases of pediatric recurrent ependymoma--a Pediatric Brain Tumor Consortium studySridharan Gururangan, Jason Fangusaro, Tina Young Poussaint, et al.
Neuro-Oncology|June 20, 2012
Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR ImagingRamon F Barajas, Joanna J Phillips, Rupa Parvataneni, et al.
Neuro-Oncology|June 20, 2012
Clinical and molecular characteristics of congenital glioblastomaMargaret E Macy, Diane K Birks, Valerie N Barton, et al.
Neuro-Oncology|June 20, 2012
18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumabRobert J Harris, Timothy F Cloughesy, Whitney B Pope, et al.
Neuro-Oncology|July 4, 2012
RNAi-mediated inhibition of presenilin 2 inhibits glioma cell growth and invasion and is involved in the regulation of Nrg1/ErbB signalingBei Liu, Liang Wang, Liang-Liang Shen, et al.
Neuro-Oncology|July 4, 2012
PTEN promoter methylation and activation of the PI3K/Akt/mTOR pathway in pediatric gliomas and influence on clinical outcomeSabine Mueller, Joanna Phillips, Arzu Onar-Thomas, et al.
Neuro-Oncology|June 28, 2012
Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results programBrad E Zacharia, Samuel S Bruce, Hannah Goldstein, et al.
Neuro-Oncology|March 24, 2010
Allergy and inflammatory transcriptome is predominantly negatively correlated with CD133 expression in glioblastomaJudith A Schwartzbaum, Kun Huang, Sean Lawler, et al.
Pageof 316